DepoMed Turns To Profit In Q4; Issues FY14 Outlook - Quick Facts

(RTTNews) - DepoMed Inc. (DEPO) posted fourth-quarter net income of $41.8 million, or $0.72 per share, compared to net loss of $3.7 million, or $0.07 per share in the comparable quarter last year.

Total revenues for the latest fourth quarter were $40.61 million, up from $26.59 million last year.

On average, three analysts polled by Thomson Reuters expected the company to report a loss of $0.20 per share on revenues of $19.06 million. Analysts' estimates typically exclude special items.

Looking ahead to full year 2014, the company expects GAAP earnings per share of approximately $0.21 to $0.36 per share, non-GAAP adjusted earnings per share of break-even to $0.16 per share and total revenues of about $200 to $215 million. Analysts currently expect loss of $0.08 per share on revenues of $132.93 million.